BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36798918)

  • 1. Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
    Sheikhi V; Heidari Z
    Adv Biomed Res; 2022; 11():124. PubMed ID: 36798918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical Hypothyroidism Is a Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.
    Heidari Z; Asadzadeh R
    Med J Islam Repub Iran; 2021; 35():186. PubMed ID: 36042831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic Fatty Liver Disease in Overt Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital.
    Augustine S; Harshitha R; Sangayya Hiremath R; Anil Kumar H; Prajwal KC
    Cureus; 2023 Apr; 15(4):e37094. PubMed ID: 37153275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus.
    Cho JH; Kim HJ; Lee JH; Park IR; Moon JS; Yoon JS; Lee IK; Won KC; Lee HW
    Korean J Intern Med; 2016 Jul; 31(4):703-11. PubMed ID: 27271351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders.
    Feisa SV; Chopei IV
    Wiad Lek; 2018; 71(2 pt 1):261-264. PubMed ID: 29729151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease.
    Tahara K; Akahane T; Namisaki T; Moriya K; Kawaratani H; Kaji K; Takaya H; Sawada Y; Shimozato N; Sato S; Saikawa S; Nakanishi K; Kubo T; Fujinaga Y; Furukawa M; Kitagawa K; Ozutsumi T; Tsuji Y; Kaya D; Ogawa H; Takagi H; Ishida K; Mitoro A; Yoshiji H
    JGH Open; 2020 Jun; 4(3):400-404. PubMed ID: 32514444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
    Mantovani A; Pernigo M; Bergamini C; Bonapace S; Lipari P; Pichiri I; Bertolini L; Valbusa F; Barbieri E; Zoppini G; Bonora E; Targher G
    PLoS One; 2015; 10(8):e0135329. PubMed ID: 26252899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study.
    Almomani A; Hitawala AA; Kumar P; Alqaisi S; Alshaikh D; Alkhayyat M; Asaad I
    World J Hepatol; 2022 Mar; 14(3):551-558. PubMed ID: 35582287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors.
    Butt AS; Hamid S; Haider Z; Sharif F; Salih M; Awan S; Khan AA; Akhter J
    Euroasian J Hepatogastroenterol; 2019; 9(1):9-13. PubMed ID: 31988860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Mantovani A; Taverna A; Cappelli D; Beatrice G; Csermely A; Sani E; Byrne CD; Targher G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-Sectional Study of the Correlation Between the Atherogenic Index of Plasma and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Lin J; Li H; Wan Q
    Diabetes Metab Syndr Obes; 2022; 15():2227-2234. PubMed ID: 35936051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients.
    Huang B; Yang S; Ye S
    J Diabetes Res; 2020; 2020():6538208. PubMed ID: 32964054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hypothyroidism in nonalcoholic fatty liver disease in patients attending a tertiary hospital in western India.
    Parikh P; Phadke A; Sawant P
    Indian J Gastroenterol; 2015 Mar; 34(2):169-73. PubMed ID: 25875369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study.
    Assarrar I; Messaoudi N; Ongoth FEM; Abdellaoui W; Malki A; Rouf S; Abda N; Ismaili Z; Latrech H
    Rev Diabet Stud; 2022 Sep; 18(3):140-145. PubMed ID: 36309775
    [No Abstract]   [Full Text] [Related]  

  • 20. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.